Advances in development of a contraceptive vaccine against human chorionic gonadotropin

@article{Talwar2015AdvancesID,
  title={Advances in development of a contraceptive vaccine against human chorionic gonadotropin},
  author={Gursaran P. Talwar and Jagdish Chandra Gupta and Susana B. Rulli and Radhey Shyam Sharma and Kripa N. Nand and Atmaram H. Bandivdekar and Nishu Atrey and Priyanka Singh},
  journal={Expert Opinion on Biological Therapy},
  year={2015},
  volume={15},
  pages={1183 - 1190}
}
Introduction: There is continuing need for contraceptives. According to World Health Organization, 210 million pregnancies occur each year, out of which some 80 million are unintended. A vaccine offering privacy and periodic intake would be an attractive proposition. Areas covered: The article is a brief review of three vaccines developed against human chorionic gonadotropin (hCG) with progressively better attributes. Clinical trials have proven in more than one country the complete safety and… 
View on Taylor & Francis
ncbi.nlm.nih.gov
3 Citations
Highly Influential Citations
2
Background Citations
2
Methods Citations
1
Results Citations
1

3 Citations

HCG Found in WHO Tetanus Vaccine in Kenya Raises Concern in the Developing World
TLDR
It is the opinion that the Kenya “anti-tetanus” campaign was reasonably called into question by the Kenya Catholic Doctors Association as a front for population growth reduction.
Strategies for successful designing of immunocontraceptive vaccines and recent updates in vaccine development against sexually transmitted infections - A review
Molecular modeling of human chorionic gonadotropin glycosylation, nicking, and carboxyl terminal extension

References

SHOWING 1-10 OF 18 REFERENCES
Phase I clinical trials with three formulations of anti-human chorionic gonadotropin vaccine.
A vaccine that prevents pregnancy in women.
TLDR
Evidence of the feasibility of a vaccine for control of human fertility is presented, consisting of a heterospecies dimer of the beta sub unit of human chorionic gonadotropin associated noncovalently with the alpha subunit of ovine luteinizing hormone, that induces antibodies of high avidity against hCG.
Mycobacterium indicus pranii is a potent immunomodulator for a recombinant vaccine against human chorionic gonadotropin.
Isoimmunization against human chorionic gonadotropin with conjugates of processed beta-subunit of the hormone and tetanus toxoid.
The immunogenicity of the conjugate prepared from "processed" beta-subunit of human chorionic gonadotropin (choriogonadotropin, HCG) and tetanus toxoid has been studied in animals and a human…
Observations on the antigenicity and clinical effects of a candidate antipregnancy vaccine: beta-subunit of human chorionic gonadotropin linked to tetanus toxoid.
An improved immunogen for anti-human chorionic gonadotropin vaccine eliciting antibodies reactive with a conformation native to the hormone without cross-reaction with human follicle stimulating hormone and human thyroid stimulating hormone.
Preparation and Formulation of a Human Chorionic Gonadotropin Antifertility Vaccine: Selection of Adjuvant and Vehicle *
TLDR
Data was obtained suggesting that the coupling of a peptide antigen and a peptides adjuvant to the same carrier holds promise as a model for vaccine development.
Regain of Fertility and Normality of Progeny Born During Below Protective Threshold Antibody Titers in Women Immunized With the HSD‐hCG Vaccine
PROBLEM: Phase II clinical trials with the heterospecies dimer of βhCG and α‐subunit of ovine luteinizing hormone (HSD)‐human chorionic gonadotropin (hCG) vaccine showed that pregnancy was prevented…
Analysis of menstrual records of women immunized with anti-hCG vaccines inducing antibodies partially cross-reactive with hLH.
An immunotherapeutic vaccine for multibacillary leprosy.
TLDR
The vaccine has completed phase III immunotherapeutic trials as an adjunct to chemotherapy in urban and rural leprosy control centres and has received the authorization from the Drugs Controller of India for industrial manufacture.
...
...